How much does Tumour Panel (Female) cost?

Tumour Panel (Female) cost is Rs.3500, although it is now available for Rs.1999 because of the offer.

Book Jaanch - Tumour Panel Test - Female

What is Tumour Panel (Female)

Tumour Panel (Female) gives you an accurate diagnosis of cancer at an early stage. Consisting of 6 parameters, the panel helps doctors understand the specific type of cancer, plan a treatment or check the progress of treatment. You can also take this test if you have just finished your cancer treatment, if you have a family history of cancer or if you are at risk due to factors like obesity, smoking, old age, and preexisting health conditions. Get Tumour Panel (Female) at affordable rates with FREE home sample collection.

About Tumour Panel (Female)

Tumour Panel (Female) blood tests can provide valuable information in the context of female-specific cancers such as:

CA-125: CA-125 is a tumor marker that can be measured in the blood. It is primarily used in the diagnosis and monitoring of ovarian cancer. Elevated CA-125 levels may indicate the presence of ovarian cancer, although further diagnostic procedures, such as imaging or biopsies, are typically required for a definitive diagnosis.
CA 15-3: CA 15-3 is a tumor marker primarily associated with breast cancer. It measures the level of a protein called carbohydrate antigen 15-3 in the blood. Elevated levels of CA 15-3 may indicate the presence of breast cancer, particularly in individuals with advanced or metastatic disease. CA 15-3 levels can be useful in monitoring response to treatment and tracking disease progression in breast cancer patients.
CA 19-9: CA 19-9 is a tumor marker used mainly in the evaluation of pancreatic and gastrointestinal cancers, including pancreatic, colorectal, and gastric cancers. It measures the level of a specific carbohydrate antigen in the blood. Elevated CA 19-9 levels can be indicative of these types of cancers, but they can also be elevated in certain non-cancerous conditions. CA 19-9 is often used to monitor treatment response and disease recurrence in pancreatic cancer patients.
Carcinoembryonic Antigen (CEA): CEA is a tumor marker that is associated with several types of cancers, most notably colorectal cancer. It is also used in the diagnosis and monitoring of other gastrointestinal cancers, such as pancreatic, liver, and lung cancers. Elevated CEA levels can indicate the presence of these cancers, but they can also be elevated in non-cancerous conditions, such as inflammatory bowel disease or smoking. CEA levels are monitored during and after treatment to assess response and detect cancer recurrence.
Alpha-Fetoprotein (AFP): AFP is a protein produced by the developing fetus, and elevated levels of AFP in the blood can indicate certain medical conditions, including liver diseases and certain cancers. In the context of cancer, AFP is primarily used in the diagnosis and monitoring of hepatocellular carcinoma (HCC), a type of liver cancer, and non-seminomatous germ cell tumors, such as testicular cancer.